Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
about
Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advancesConcerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motilityIGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy ResistanceRole of insulin-like growth factors and their binding proteins in growth control and carcinogenesis.Inhibition of apoptosis by amphiregulin via an insulin-like growth factor-1 receptor-dependent pathway in non-small cell lung cancer cell lines.The impact of host diet on Wolbachia titer in DrosophilaSerine phosphorylation of the insulin-like growth factor I (IGF-1) receptor C-terminal tail restrains kinase activity and cell growthModulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity.Type I insulin-like growth factor receptor signaling in hematological malignancies.Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration.Impaired Shc, Ras, and MAPK activation but normal Akt activation in FL5.12 cells expressing an insulin-like growth factor I receptor mutated at tyrosines 1250 and 1251.Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair.Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit.
P2860
Q21131281-385BADC9-A769-40F7-AD93-9D0BA350D0E0Q24554511-855ADBE2-A612-4713-9ABB-B3BF2D80E4ACQ26802042-2A2A61E2-799E-4379-A833-FF65401C0158Q33853206-ED210428-1643-42C3-B664-30DF0BDAD04CQ34152476-A12638E3-A35F-4E87-83AB-D68EF7F3BE19Q35235115-07B7D597-2F55-4C15-83A4-BF0A3FF42FA6Q36201972-335BFC81-CF6C-4706-94F0-14BA6CE4A8C5Q37192214-840A4B02-8178-45CE-AC53-06A6D635DE0AQ37702186-40EF0B6B-3C95-487C-B7EE-A601898DB1EFQ39970150-60807AE3-6940-4517-BD61-2C88AEA45794Q40590032-D9E85F4A-C9D8-48F6-B8F3-FF96E5C0A5CAQ42830476-606A94AD-4740-4F66-8F98-495D6C8E8127Q43668389-A968C1E6-3F79-4860-BE35-8C91FB2F6330
P2860
Replacement of tyrosine 1251 in the carboxyl terminus of the insulin-like growth factor-I receptor disrupts the actin cytoskeleton and inhibits proliferation and anchorage-independent growth.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@en
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@nl
type
label
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@en
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@nl
prefLabel
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@en
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@nl
P2093
P2860
P356
P1476
Replacement of tyrosine 1251 i ...... anchorage-independent growth.
@en
P2093
Blakesley VA
Scrimgeour A
Stannard BS
P2860
P304
18411-18422
P356
10.1074/JBC.273.29.18411
P407
P577
1998-07-01T00:00:00Z